![Christophe Valat](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christophe Valat
Corporate Officer/Principal at CellProthera SAS
Profile
Christophe Valat is the founder of Serial Genetics SAS, which was founded in 2002.
He held the title of Chief Executive Officer & Chief Scientific Officer from 2012 to 2013.
Currently, he is the Chief Development Officer at CellProthera SAS since 2011.
In the past, he worked as a Principal at IP2IPO Innovations Ltd.
Christophe Valat active positions
Companies | Position | Start |
---|---|---|
CellProthera SAS
![]() CellProthera SAS Medical/Nursing ServicesHealth Services CellProthera SAS operates as a holding company with interests in medical studies on heart diseases. The firm focuses on the development of a stem cell therapy for the regeneration of myocardial tissue allowing the prevention of chronic heart failure following acute myocardial infarct by injecting a cell graft containing antilogous adult stem cells sampled directly from the patient. The company was founded by Philippe H?non in April 2008 and is headquartered in Mulhouse, France. | Corporate Officer/Principal | 31/12/2010 |
Former positions of Christophe Valat
Companies | Position | End |
---|---|---|
Serial Genetics SAS
![]() Serial Genetics SAS Medical SpecialtiesHealth Technology Serial Genetics designs, develops and sells genetics analysis kits based on its proprietary technology, HairLoop and mutation discovery tools, based on the Endo-1 enzyme. Serial Genetics is an active partner of the 'Medicen Paris Region' competitiveness hub, dedicated to health and pharmaceutical research. Based in Evry, France, Serial Genetics is ideally situated in the hearth of the Genopole, the French largest cluster of biotech companies and genetic academic labs. | Founder | 21/02/2013 |
IP2IPO Innovations Ltd.
![]() IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
IP2IPO Innovations Ltd.
![]() IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Commercial Services |
Serial Genetics SAS
![]() Serial Genetics SAS Medical SpecialtiesHealth Technology Serial Genetics designs, develops and sells genetics analysis kits based on its proprietary technology, HairLoop and mutation discovery tools, based on the Endo-1 enzyme. Serial Genetics is an active partner of the 'Medicen Paris Region' competitiveness hub, dedicated to health and pharmaceutical research. Based in Evry, France, Serial Genetics is ideally situated in the hearth of the Genopole, the French largest cluster of biotech companies and genetic academic labs. | Health Technology |
CellProthera SAS
![]() CellProthera SAS Medical/Nursing ServicesHealth Services CellProthera SAS operates as a holding company with interests in medical studies on heart diseases. The firm focuses on the development of a stem cell therapy for the regeneration of myocardial tissue allowing the prevention of chronic heart failure following acute myocardial infarct by injecting a cell graft containing antilogous adult stem cells sampled directly from the patient. The company was founded by Philippe H?non in April 2008 and is headquartered in Mulhouse, France. | Health Services |
- Stock Market
- Insiders
- Christophe Valat